Secondly, we also examined these phenotypes in the context of the autoimmune disease model of multiple sclerosis, where pretreatment of murine MSCs with TLR3 and TLR4 agonists generates distinct and opposing immunomodulatory effects on EAE. This evidence concerns the gene TLR4 and autoimmune disease.